Boldly transforming the lives of individuals with rare neurological diseases
Science-driven and patient-focused, our mission is to develop medicines that transform the lives of patients with epilepsies and seizure-related disorders.
Our deep understanding of human genetics and cellular function enables us to translate discoveries into meaningful therapies for epilepsies and seizure-related disorders.
At Ovid, we seek to understand what matters most to individuals with rare diseases and their families. We are committed to address the challenges they face every day.
- Ovid Therapeutics Reports First Quarter 2022 Financial Results and Corporate Highlights
- Ovid Therapeutics to Present at the 21st Annual Needham Virtual Healthcare Conference
- Ovid Therapeutics Reports Business Update, Fourth Quarter and Full Year 2021 Financial Results
- Ovid Therapeutics to Participate at the Cowen 42nd Annual Health Care Conference